在丸胚芽细胞瘤中的RAS/甲基因激活蛋白激酶信号通路
Angelo Onorato1, Eugenia Guida1, Ambra Colopi1
1Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
Life (Basel, Switzerland)
|March 28, 2024
概括
丸生殖细胞瘤 (TGCTs) 涉及KIT和K-RAS等关键基因. 研究探索了KIT-RAS途径,以在这些罕见的癌症中寻找潜在的精准医学点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 胚胎细胞瘤 (GCTs) 是年轻男性 (15-40岁) 中最常见的丸癌.
- TGCTs表现出高体积和少数体质突变,其中KIT和K-RAS是显著突变的基因.
- 受体氨酸激酶 (RTK) 和基激活蛋白激酶 (MAPK) 途径调节关键的细胞功能,并与各种癌症有关.
研究的目的:
- 审查遗传和表观遗传因素在丸生殖细胞瘤 (TGCT) 发病过程中的作用.
- 检查KIT-RAS通路在TGCT和其他癌症中的参与.
- 突出TGCTs中精准医学的潜在可向标记.
主要方法:
- 现有文献的叙述性审查.
- 对基因组和转录组数据的分析.
- 专注于PGC的生存,扩散,分化和TGCT的病原性.
主要成果:
- 确定KIT和K-RAS是TGCT中显著突变的基因.
- 强调RTK/MAPK途径在TGCT发展中的重要性.
- 强调了针对这一途径的精准医学方法的潜力.
结论:
- 该KIT-RAS通路是理解TGCT病原学的关键领域.
- 准KIT-RAS途径为丸癌的新型精确疗法提供了希望.
- 对分子标记物的进一步研究对于推进TGCT治疗至关重要.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


